Login / Signup

SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from AHA.

Eri Toda KatoKoh OnoBasil S Lewis
Published in: European heart journal. Cardiovascular pharmacotherapy (2023)
Keyphrases
  • acute myocardial infarction
  • phase iii
  • percutaneous coronary intervention
  • study protocol
  • left ventricular
  • phase ii
  • clinical trial
  • randomized controlled trial
  • coronary artery disease
  • atrial fibrillation